Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Allersoothe
Active Ingredient: Promethazine hydrochloride 1mg/mL
Dosage Form: Elixir
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Hoe Pharmaceuticals Sdn. Bhd., Bandar Sultan Suleiman, Pelabuhan Klang, Selangor, Malaysia
Product: Ceftazidime
Active Ingredient: Ceftazidime pentahydrate 291mg equivalent to ceftazidime 250mg
Dosage Form: Powder for injection
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Laboratorio Farmaceutico CT SrL, San Remo (IM), Italy
Product: Ceftazidime
Active Ingredient: Ceftazidime pentahydrate 582mg equivalent to ceftazidime 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Laboratorio Farmaceutico CT SrL, San Remo (IM), Italy
Product: Ceftazidime
Active Ingredient: Ceftazidime pentahydrate 1.164g equivalent to ceftazidime 1g
Dosage Form: Powder for injection
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Laboratorio Farmaceutico CT SrL, San Remo (IM), Italy
Product: Ceftazidime
Active Ingredient: Ceftazidime pentahydrate 2.328g equivalent to ceftazidime 2g
Dosage Form: Powder for injection
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Laboratorio Farmaceutico CT SrL, San Remo (IM), Italy
Product: OxyContin
Active Ingredient: Oxycodone hydrochloride 15mg equivalent to oxycodone 13.5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product: OxyContin
Active Ingredient: Oxycodone hydrochloride 30mg equivalent to oxycodone 27mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Dated this 3rd day of July 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).